SAVA Announcement: Reach out to Kessler Topaz Meltzer & Check, LLP for Securities Inquiries
Investors who have suffered losses in Cassava Sciences, Inc. securities are encouraged to contact the law firm Kessler Topaz Meltzer & Check, LLP regarding a new class action lawsuit. The lawsuit is based on allegations that Cassava Sciences made false and misleading statements about its drug candidate simufilam, as well as its interactions with the FDA. These alleged misrepresentations artificially inflated the company’s stock price, causing investors to suffer losses when the truth was revealed.
The class action lawsuit, filed in the United States District Court for the Western District of Texas, alleges that Cassava Sciences made false and misleading statements regarding the results of its interim data analysis for its Phase 2b clinical study of simufilam. The company claimed that the data showed positive results in all safety and clinical measures, leading to a significant increase in its stock price. However, it is alleged that the data was actually inconclusive and did not support the company’s claims of efficacy.
Furthermore, the lawsuit alleges that Cassava Sciences failed to disclose important information about its interactions with the FDA regarding the development of simufilam. The company supposedly claimed that it had positive communications with the FDA and that the agency supported its clinical program. However, it is alleged that the FDA actually expressed concerns about the data submitted by Cassava Sciences and requested additional information.
As a result of these alleged misrepresentations and omissions, Cassava Sciences’ stock price plummeted when the truth was revealed. Investors who purchased the company’s securities during the relevant time period suffered significant losses as a result. The class action lawsuit seeks to recover damages on behalf of investors who were harmed by the company’s alleged misconduct.
Investors who purchased Cassava Sciences securities between February 2, 2021, and September 14, 2021, are encouraged to contact Kessler Topaz Meltzer & Check, LLP to discuss their legal rights. The law firm specializes in securities litigation and has a track record of success in holding companies accountable for their misconduct. By contacting the firm, investors can learn more about the class action lawsuit and determine if they are eligible to participate in the litigation.
Overall, the class action lawsuit against Cassava Sciences, Inc. highlights the importance of holding companies accountable for their actions. Investors who have suffered losses due to alleged securities fraud deserve to seek justice and recover damages for their losses. By contacting a reputable law firm like Kessler Topaz Meltzer & Check, LLP, investors can take steps to protect their rights and potentially recover losses incurred as a result of alleged misconduct in the securities market.
